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Abstract 
 
 
Consanguinity is a deeply rooted cultural trait in Middle Eastern societies, especially in the 
Arab rural populations due to socio-cultural factors like maintenance of family structure, 
property or ease of marital arrangements.Thus Autosomal recessive retinitis pigmentosa 
genes are highly associated with consanguineous families.  
 
The prevalence of autosomal hereditary recessive diseases is high in Middle Eastern Arab 
societies, mainly due to the high rate of consanguineous marriages. In clinical genetics, this 
includes relationships of second cousins or closer.   
 
we designed an ARMS (Amplification ‐ Refractory Mutation System ) technique for the 
three autosomal recessive genes FAM161, CNGA3, and CRB1.In this study we developed 
an ARMS technique for the three autosomal recessive genes FAM161, CNGA3, and CRB1 
in 18 Palestinian families with consanguinious marriages.We succeeded in designing 
cheaper methods for detecting these genes.  
 
ARMS is a simple method for detecting any mutation involving single base changes or 
small deletions. ARMS is based on the use of sequence‐specific PCR primers that allow 
amplification of target DNA sequence only when the target allele is contained within the 
sample. ARMS allows genotyping solely by inspection of reaction mixtures after agarose 
gel  electrophoresis. The system is simple, reliable and non-isotopic. It will clearly 
distinguish heterozygotes at a locus from homozygotes for either allele. It is a economic 
approach that can use standard laboratory equipment. 
 
 Another use is the identification of SNPs restriction fragment length polymorphism 
(RFLP), in which a difference in homologous DNA sequences can be detected by the 
presence of fragments of different lengths after digestion of the DNA samples in question 
with specific restriction endonucleases. The presence or absence of the restriction site can 
be determined by agarose gel electrophoresis of the digested fragments and visualization 
using ethidium bromide staining and ultraviolet (UV) illumination . 
 
 
 
III 
 
During the study period, 18 families with ophthalmological diseases on a consanguineous 
background in Arab villages of Palestine were recruited , and ARMS technique used to 
identify genetic mutations. 
 
Two mutations out of the three propsed could be identified : FAM161 
(c.1003C>T/p.R335X), CNGA3 (c.985G>T ‐ Gly329Cys) and CRB1 gene wasn‘t identifed 
by this technique. The results demonstrate that we succeeded in designing a cheap and 
timesaving method for detecting these genes. 
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Chapter 1 
 
1. Introduction 
 
Consanguinity is derived from two Latin words "con" meaning common, or of the same 
and "sanguineous" meaning blood, hence, referring to a relationship between two people 
who share a common ancestor. In other words, consanguineous marriage refers to the 
union contracted between biologically related individuals; union between couples who are 
related as second cousins or closer (Alwan and Modell, 1997; Modell and Darr, 2002). 
 
1.1  Consanguinity in World Populations 
Consanguineous marriages have been practiced since the early existence of modern 
humans. At present, about 20% of world populations live in communities with a preference 
for consanguineous marriage (Modell and Darr, 2002). Consanguinity rates vary from one 
population to another depending on religion, culture and geography. Noticeably, many 
Arab countries display some of the highest rates of consanguineous marriages in the world 
ranging around 20-50% of all marriages, and specifically favoring first cousin marriages 
with average rates of about 20-30% as showed in (Fig. 1.1). 
 
 
Figure 1.1: Schematic representation of consanguineous marriage rates worldwide (Tadmouri, 2008).
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1.2  Consanguinity in Arab Populations 
Consanguinity rates show wide variations among Arab countries, as well as within the same 
country as showed in (Table 1.1). However, reports from Arab countries on consanguinity rates 
may sometimes include marriages between third cousins or far relatives within the 
consanguineous category. Although this discrepancy affects the total consanguinity rate, it does 
not markedly alter the average inbreeding coefficient (Tadmouri, 2008). 
Therefore, for comparison of consanguinity rates among populations, two parameters are best 
used; the mean inbreeding coefficient (F) and marriages between first cousins. However, Arab 
societies have a long tradition of consanguinity, and the cumulative estimate of (F) may exceed 
the estimated value which is calculated for a single generation ( Bittles et al., 1993).  
 
Table 1.1: Consanguinity rates in arab population (Tadmouri, 2008).  IC: First cousin,  >IC : Second cousin                                                              
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Consanguineous marriages are generally thought to be more stable than marriages between non-
relatives, though there are no studies to compare divorce rates of consanguineous and non-
consanguineous marriages among Arabs. It is generally believed that the husband's family would 
side with the consanguineous wife in marital disputes since she is considered part of the 
extended family. When there are children with disabilities, more family members share in caring 
for these children (Khlat, 1988). 
1.3 Consanguinity in Palestine: 
 
Many Arab countries display some of the highest rates of consanguineous marriage in the world 
ranges between 20-50% of all marriages (Bittles, 2008). Among Palestinian Arabs the rate of 
consanguinity is very high and some 44.3% of the marriages are between relatives (22.6% of 
them between first cousins). Secular changes in the consanguinity rates have been noticed in 
some Arab populations. In Jordan (Hamamy et al., 2005), Palestine (Sharkia et al., 2008), Egypt 
(Hafez et al., 1983) as showed  in (Table 1.1),the frequency of consanguineous marriage is 
decreasing. Several factors may be playing a role in the decrease of consanguinity rates in 
Palestine . Amongst these factors are higher female education levels, declining fertility resulting 
in lower number of suitable relatives to marry, more mobility from rural to urban settings, and 
the improving economic status of families (Bittles et al., 1993). 
 
Genetic analysis shows that Palestinians are of mainly of Levantine ancestry, most similar to 
Syrians, Lebanese, Jordanians, Cretans and Egyptians. The Palestinian population was 3,761,646 
in 2007; of these, 2,345,107 are residents of the West Bank, including 208,000 in East Jerusalem. 
High consanguinity rates have been reported in Muslim Arabs (44 %) and Druze (47 %). There 
is little available data regarding genetic disorders in the Palestinian territories; however, there are 
hundreds of genetic disorders among Palestinians living in the West Bank and Gaza Strip 
(Hussein et al., 2010). 
 
The Palestinian population is characterized by high consanguinity rates (about 44 %), large 
family size (5.5 children per family), and pregnancies in women over the age of 45. These 
factors result in the high incidence of genetic disorders, particularly the increase in rare recessive 
genetic disorders (Hussein et al., 2010). 
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1.4 Negative Effects of Consanguinity on Reproductive Health 
 
1.4.1 Consanguinity and Congenital Malformations: 
 
Approximately 3-5% of all live newborns have a medically significant birth defect. The recent 
report by March of Dimes estimated birth defects to be >69.9/1000 live births in most Arab 
countries, as opposed to <52.1/1000 live births in Europe, North America and Australia 
(Christianson et al., 2006) and lower observed rates of 12.5/1000 defects births was registered in 
the Kuwait (Madi et al., 2005). A strong association of consanguinity with poverty and low 
education points to the need to avoid exposure to environmental hazards in these families 
(Harlap et al., 2008). In addition, the risk of birth defects in first cousin marriages may be 
estimated to be 2-2.5 times the general population rate, mainly due to the expression of 
autosomal recessive disorder (Bennett et al., 2002; Murshid et al., 2000; Murshid, 2000). 
Consanguinity rates were noted to be higher among parents of newborns with congenital 
hydrocephalus and neural tube defects  than in the general population in some studies, but not in 
the others (Khlat and Khoury, 1991). A positive association of consanguinity with cleft lip and 
palate was reported in Palestine (Bittles and Black, 2010). 
1.4.2 Consanguinity and Postnatal Mortality: 
Countries with high rates of consanguineous marriages generally report smaller effects of 
consanguinity on mortality than populations with low rates of consanguineous marriages. This 
finding is not surprising, given the limited control for concomitant variables such as 
socioeconomic status, maternal education, birth intervals, and public health facilities and 
practices in most consanguinity studies (Khlat and Khoury, 1991). 
The most recent mortality estimate derived from a multinational study of over 600,000 
pregnancies and live births is that first cousin progeny experience 4.4% more pre-reproductive 
deaths than the offspring of non-consanguineous unions (Bittles and Neel, 1994).  
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Most studies among Arabs have indicated that postnatal mortality is higher among offspring of 
consanguineous parents than among non-related parents.The increased postnatal mortality among 
the offspring of consanguineous parents may be related to the effect of deleterious recessive 
genes and multi-gene complexes inherited from a common ancestor (Khlat, 1988).  
1.4.3 Consanguinity and Autosomal Recessive Disorders: 
In offering preconception counseling for consanguinity, it is crucial to distinguish between 
families with a known genetic or inherited disorder and those with unknown disorder by taking a 
detailed family history and constructing a four-generation pedigree (Bennett et al., 2002).  
Reports have shown that in certain clinical settings, practice guidelines regarding collecting 
information on consanguinity as part of family history are not available despite the relevance of 
such history in identifying at risk pregnancies. Specific questions addressed to the couple could 
help in eliciting the presence of a genetic or hereditary disorder in the extended family (Bishop et 
al., 2008). These could include inquiry about the presence of any of the following in blood 
relatives: 
 Birth defects or congenital anomalies. 
 Early hearing impairment. 
 Early vision impairment. 
 Mental retardation or learning disability. 
 Developmental delay or failure to thrive. 
 An inherited blood disorder. 
 Unexplained neonatal or infant death in offspring. 
 
Inbreeding depression in human health is the major focus of interest in hereditary and medical 
genetics. Inbreeding increases the coefficient of autosomal recessive genes, which in turn 
increases the probability of the expression of pathogenic mutations in a homozygous state. 
Autosomal recessive disorders occur in individuals who have two copies of an allele for a 
particular recessive genetic mutation (Zhang, 2005).  
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An analysis of data in the Catalogue for Transmission Genetics in Arabs (CTGA), a database on 
genetic disorders in Arab populations maintained by the Centre for Arab Genomic Studies, 
indicates that in contrast to international databases, the overwhelming proportion of the disorders 
in the CTGA Database follow a recessive mode of inheritance (63%) compared to the smaller 
proportion of dominantly inherited traits (27%). A detailed study of countries for which surveys 
on the occurrence of genetic disorders have been completed (United Arab Emirates, Bahrain, and 
Oman) indicates that recessive disorders are more in number than the dominant ones  (Tadmouri, 
2008).  
As explained above, given the high rates of consanguinity in these countries, this pattern is not 
entirely surprising. In a study from Jordan, the consanguinity rate among parents affected by 
autosomal recessive conditions was around 85%, while it was 25-30% among parents affected by 
other genetic conditions such as X-linked recessive, chromosomal and autosomal dominant ( 
Hamamy et al., 2005 ). 
1.5  Autosomal Recessive disorder and Ophthalmic Disease in Palestine 
 
As a consequence of the high consanguinity rate among the Palestinian, many recessive disorders 
are present with a relatively high frequency. In 1997, a survey of 2000 different Palestinian Arab 
families who visited genetic clinic in palestine,  601 an autosomal recessive disease were 
diagnosed. The distribution of these disorders was not uniform and some disorders such as 
Krabbe disease were found at high frequency in only a small part of the population. For other 
disorders, a high prevalence was also reported among Palestinian Arabs living in other regions, 
for example, thalassaemia, Bardet-Biedl syndrome, Meckel syndrome, retinopathy, and recessive 
osteopetrosis (Genet, 1997).  
 
In this study, we were interested in inherited ophthalmic disorders observed in consanguineous 
marriage. However, a special attention was paid to ophthalmic retinal disorders  “retinopathy” , 
many recent publications illustrating novel mutations in genes   expressed in retinal epithelium 
cells that eventually leads to blindness and loss of vision in consanguineous Palestine family.  
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1.6 Anatomy of the Eye  
 
 
Eyes are sense organs that  providing organisms with vision. The ability to process visual details, 
as well as enabling several photo response functions that are independent of vision. Eyes 
detect light and convert it into electro-chemical impulses in neurons. In higher organisms, the 
eye is a complex optical system which collects light from the surrounding environment, regulates 
its intensity through a diaphragm, focuses it through an adjustable assembly of lenses to form an 
image, converts this image into a set of electrical signals, and transmits these signals to 
the brain through complex neural pathways that connect the eye via the optic nerve to the visual 
cortex and other areas of the brain (Land et al.,1992). 
 
The eye has three layers or coats and three fluid containing structures as shown in (Fig. 1.2). The 
outer layer is the fibrous layer, consisting of the cornea, sclera and lamina cribrosa. The middle 
vascular layer consists of the iris, ciliary body (consisting of the pars plicata and pars plana) and 
choroids. Finally, the inner nervous layer consists of  the pigment epithelium of the retina, retinal 
photoreceptors and retinal neurons (Galloway et al., 2006). 
 
 
 
 
Figure 1.2: Anatomy of eye. http://www.webmd.com/eye-health/picture-of-the-eyes#1 
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1.7 Anatomy of the Retina  
Normal retina contains neuroretina and retinal pigment epithelium. The neuroretina consists of 
outer and inner segments of photoreceptors (rods and cones), external limiting membrane, outer 
nuclear layer, outer plexiform layer, inner nuclear layer, inner plexiform layer, ganglion cell 
layer, nerve fiber layer and internal limiting membrane as in (Fig. 1.3) and (Fig. 1.4) (Melloni, 
1971; Gupta et al., 2015). 
 
There is a broad spectrum of retinal pathology including congenital abnormalities, dystrophies, 
degenerations (notably age-related macular degeneration), retinal vascular diseases, toxicities, 
inflammatory diseases, neoplasms, trauma and retinal involvement of systemic diseases  (Gupta 
et al., 2015). 
 
 
 
 
Figure 1.3: A schematic section through the human eye with a schematic enlargement of the retina (Melloni, 
1971). 
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Figure 1.4 : Photomicrograph of the retina combined with a diagram of pertinent retinal cells (Gupta et al., 2015). 
 
The fundus can be examined by ophthalmoscopy and/or fundus photography (Cassin and 
Solomon, 1990). The color of the fundus varies both between and within species.It is the interior 
surface of the eye opposite the lens and includes the retina, optic disc, macula. In one study
 
of primates the retina is blue, green, yellow, orange, and red; only the human fundus (from a 
lightly pigmented blond person) is red as shown in (Fig. 1.5). The major differences noted 
among the primate species were size and regularity of the border of macular area, size and shape 
of the optic disc, and pigmentation of the retina (Wolin and Massopust, 1967). 
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Figure 1.5: Fundus photographs of the right eye (left image) and left eye (right image).  
http://www.2c.ie/services/digital-retinal-photography.  
Eye development and photoreceptor maintenance are dependent on the retinal pigment 
epithelium (RPE), a thin layer of cells that underlie the neural retina (Leung et al., 2007). The 
(Fig. 1.6) is showing the structure of fundus.The optic disc is the anatomical location of the eye's 
"blind spot", the area where the optic nerve and blood vessels enter or leave the 
retina. The macula is an oval-shaped pigmented area near the center of the retina of the human 
eye that contain high density of cones (Cassin and Solomon, 1990). 
 
 
Figure 1.6 :  Normal fundus image. http://www.rpfightingblindness.org.uk/ 
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1.8 Inherited ophthalmic Retinal Disorder  
Genetic disorders are diseases that result from a change in the normal DNA sequence. Most 
genetic disorders are caused by multifactorial means involving a combination of genetic and 
environmental factors. Thousands of human diseases are now known to be caused by single gene 
disorders and chromosomal abnormalities, many of which involve the eye ( Al-Enezi et el., 
1998). 
The human eye is a complex and unique organ in a sense that it allows for many of the clinical 
features to be characterized with an unaided bare eye or simple ophthalmic examination tool. 
Thus the phenotypes of many ophthalmic genetic conditions had been well characterized, and the 
ophthalmic exam may offer important information in detecting the underlying genetic disorder 
(Yanoff and Duker, 2004 ).Hereditary retinal dystrophies are a broad group of genetic retinal 
disorders of varying severity and with differing inheritance patterns (Moore et al., 2008) . 
During the past twenty years, there has been an exponential increase in the knowledge and 
understanding of ocular genetic diseases and syndromes. The number of human eye diseases that 
have a known genetic or hereditary component continues to increase (Mathebula, 2012).  
Approximately 4000 genetic diseases and syndromes are known to affect humans, and at least 
one-third involve the eye. In addition, genetic diseases are the most common cause of blindness 
in infants and children in developed countries. With the development and progress of science at 
the molecular level, it becomes possible to seek and investigate of the occurrence and existence 
of the disease in patients to confirm their clinical diagnosis (Hurst, 1992 (.  
The ocular pathology can be classified into non-genetic and genetic diseases. The non-genetic 
diseases are those caused by trauma, inflammation due to foreign body or by pathogens such as 
viruses, bacteria or fungi. However, the genetic alterations that affect genes involved in the 
development and functionality of the eye can include somatic as well as inherited changes. 
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 Examples of somatic mutations that can affect the eye function include a mutation in the 
retinoblastoma gene (RB1 gene) that leads to an eye tumor called retinoblastoma. Inherited 
mutations that affect the normal physiology of the eye can occur in many genes involved in the 
vision process. Examples of these genes include MYOC gene that causes glaucoma, CHM gene 
that encodes Rab escort protein-1, and FBN1 gene which is responsible for Marfan syndrome. 
Mutations in RP38, MERTK, PDE6A, RP35, PGR, FAM161, CNGA3 and CRB1 are known to 
be the cause of the Retinitis pigmentosa (RP) (Mathebula, 2012). 
 
Fundus albipunctatus (FA) is an autosomal recessive congenital night blinding disorder 
characterized by the presence of retinal white dots caused by mutations in many genes such as 
FAM161A , CRB1 and RDH5 . It is characterized by numerous small, subretinal, white or place- 
yellow spots in the perimacula and the periphery of the retina as in (Fig. 1.7) (Simon et el., 
1999). 
 
Figure 1.7 : Fundus Albipunctatus , there are multiple yellow-white lesions at the level of the RPE. 
http://www.djo.harvard.edu/files/3697_493.jpg                                                               
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1.9  Retinitis Pigmentosa as an Autosomal Recessive Ophthalmic Disorder 
Retinitis pigmentosa (RP) is an inherited degenerative eye disease that causes severe vision 
impairment due to the progressive degeneration of the rod photoreceptor cells in the retina 
(Busskamp et al., 2010). This form of retinal dystrophy manifests initial symptoms independent 
of age; thus, RP diagnosis occurs anywhere from early infancy to late adulthood (Robert, 2003). 
Patients in the early stages of RP first notice compromised peripheral and dim light vision due to 
the decline of the rod photoreceptors. The progressive rod degeneration is later followed by 
abnormalities in the adjacent retinal pigment epithelium (RPE) and the deterioration of cone 
photoreceptor cells. Affected individuals may additionally experience defective light-dark 
adaptations, nyctalopia (night blindness), and the accumulation of bone spicules in the fundus 
(Ferrucci et al., 1998).  
 
RP is a clinically and genetically heterogeneous group of hereditary retinal disorders, being one 
of the most common types of retinal degenerations worldwide with a prevalence of 1:4000. Up to 
now, 53 genes have been associated with RP, whose defects cause a progressive loss of rod 
photoreceptor function, followed by cone photoreceptor dysfunction often leading to complete 
blindness (Ditta Zobor, 2012). An autosomal dominant retinitis pigmentosa is caused by 
mutations in RP1 gene (Ziviello, 2005). Mutations in the RPGR gene are the most frequent cause 
of X-linked retinitis pigmentosa (Meindl, 1996). Mutation in FAM161, CNGA3, and CRB1 are 
examples of autosomal recessive retinitis pigmentosa. 
 
This descriptive study was used to investigate the presence of three gene              
(FAM161A, CNGA3 and CRB1) in consanguineous Palestinian families with RB. 
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1.10  Autosomal recessive genetic disorders causing RP 
 
This study is unique in that it incorporates both clinical and molecular aspects of the disease in 
the target families. This study highlights and demonstrates the target genes (FAM161, CNGA3, 
and CRB1) that cause RP, leading to proper management of ophthalmic patients in the setup of 
diagnosis and treatment.  
 
1.10.1  Family with Sequence Similarity 161, Member A Gene (FAM161A): 
 
Family with sequence similarity 161, member A (FAM161A) is a gene expressed at the base of 
the photoreceptor connecting cilium in humans, mice and rats. Furthermore, it is also present at 
the ciliary basal body in ciliated mammalian cells, both in native conditions and upon the 
expression of recombinant tagged proteins (Di Gioia, 2012). Thus FAM161A is another member 
of the growing list of ciliary proteins implicated in human disease and FAM161A-associated RP 
must be considered as a ciliopathy (Mockel, 2011).  
 
In 2010, Langmann et al. analyzed the candidate gene FAM161A and identified a homozygous 
mutation (R229X; 613596.0001) that was found to co-segregate with disease in the family. 
Screening of FAM161A in 118 patients from Germany with recessive or sporadic forms of RP 
revealed the presence of another homozygous mutation (R437X) in 3 patients (Langmann, 2010). 
A new study on this gene using homozygosity mapping revealed a new nonsense mutation 
(c.1003C>T/p.R335X) that is responsible in causing autosomal recessive retinitis pigmentosa in 
a Palestinian family (Ditta  Zobor, 2014).
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1.10.2  Cyclic Nucleotide Gated Channel Alpha 3 Gene (CNGA3): 
 
Cyclic nucleotide gated channel alpha 3 gene causes autosomal recessive achromatopsia; a 
congenital autosomal recessively inherited disorder characterized by a lack of color 
discrimination, low visual acuity (<0.2), photophobia, and nystagmus (Kohl S, 2005 Mar). 
 
CNGA3 gene encodes one of a family of alpha subunits that form CNG ion channels required for 
sensory transduction in rod photoreceptors and in olfactory neurons. The CNG3 channel consists 
of CNGA3 and CNGB3 in a heterotetrameric structure of 2 alpha and 2 beta subunits (Sundin, 
2000). In 2001, Wissinger et al. explored the results of a first comprehensive screening for 
CNGA3 mutations in a cohort of 258 additional independent families with hereditary cone 
photoreceptor disorders including not only  patients with the complete form of achromatopsia as 
in (Fig. 1.8), but also patients with incomplete achromatopsia and even a few patients diagnosed 
with severe progressive cone dystrophy. Four mutations (R277C, R283W, R436W, and F547L) 
accounted for 41.8% of all the detected mutations (Wissinger, 2001). 
 
 
 
Figure 1.8 :  A photograph of the central retina of a "normal" on the left side and a young patient with 
achromatopsia.  http://www.achromatopsia.info/reduced-visual-acuity/. 
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Recently study on CNGA3 gene using genetic screening in the Medical College of Wisconsin 
and the University of Washington reported a mutation c.985G>T ‐ Gly329Cys in two Jordanian 
patients diagnosed with achromatopsia (Mohamed and Genead, 2011). 
 
1.10.3  Homo sapiens Crumbs Family Member 1 Gene (CRB1): 
 
Homo sapiens crumbs family member 1 (CRB1) mutations were a relatively frequent cause of 
autosomal recessive early onset retinal degeneration in Palestinian populations (10% of families 
with Leber congenital amaurosis LCA), and caused severe retinal degeneration at an early age 
(Beryozkin, 2013). LCA (the term congenital refers to a condition present from birth 
and amaurosis refers to a loss of vision) is a severe form retinal dystrophy with early childhood 
blindness (Hollander, 2008).  
 
CRB1 is positioned in a belt-like structure of the inner segments where it is believed to function 
in the maintenance of cell polarity of the photoreceptors. In a previous study on this gene, the 
gene c.3307G>A/p.Gly1103Arg mutation was detected in a patient diagnosed with LCA 
(Hanein, 2005). Moreover, the same mutation was identified in two families from the vicinity of 
Jerusalem in new recent study on this gene in Palestinian populations on retinal degeneration 
(Avigail Beryozkin, 2013). 
 
Detection of different mutations in a DNA sample, by using many techniques in clinical 
diagnostic laboratories, can lead to a diagnosis, possible prognosis, and prospective therapy 
treatments. For example, single-nucleotide polymorphism arrays (SNP array) is a technique used 
in detection of mutations, while Sanger sequencing is a technique used to detect unknown 
mutation by amplifying PCR products of a particular region of interest (Wong, 2013)
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The Objectives and aims  
 
The study aim to: 
 
- Screening for specific genetic mutations in ophthalmic patients for consanguineous 
families. 
- Highlight the role of molecular technique in retinopathies diagnosis. 
- Develop a molecular technique for ophthalmic genetic mutation screening. 
 
The Significance of the study 
 
The Palestinian population is known to have a relatively high level of consanguineous 
marriages, leading to a relatively high frequency of autosomal recessive (AR) diseases. Our 
purpose was to use the homozygosity mapping approach, aiming to prioritize the set of 
genes and identify the molecular genetic causes underlying AR retinal degenerations in the 
Palestinian population . 
 
Inclusion and Exclusion Criteria  
 
The inclusion criteria of our study is more than one  Palestinian ophthalmic patient 
suffering from reduced vision, retinopathy, or night blindness derived from parents of  
consanguineous marriage, the ophthalmic disorder with no gender or age preference. 
 
The exclusion criteria include ophthalmic patient from non consanguineous families, one 
only affected patient from consanguineous family, and other non inherited ophthalmology 
disorders.  
 
 
 
 
 
 
 
 
18 
 
1.11. Literature Review 
 
1.11.1 Family with Sequence Similarity 161 Member A: 
 
Retinitis pigmentosa (RP) is a hereditary disease that leads to the progressive degeneration 
of retinal photoreceptor cells and to blindness. It is caused by mutations in several distinct 
genes, including the ciliary gene FAM161A, which is associated with a recessive form of 
this disorder (Berson, 1993). Mutations in FAM161A have been found to represent the 
cause of RP28-associated autosomal recessive RP (arRP) in the initial Indian family in 
which the RP28 locus was mapped (Gu et al., 1999). 
 
By searching for genes within the retinitis pigmentosa-28 locus on chromosome 2,the 
researcher identified the FAM161A gene. The most abundant FAM161A transcript 
encodes a deduced 660-amino acid protein. Quantitative RT-PCR detected 
both FAM161A variants in all tissues examined. The short variant showed highest 
expression in testis, followed by retina, heart, and liver. The long variant showed highest 
expression in retina, followed by testis, liver, heart, and muscle (Langmann et al., 2010). In 
previously studied, Using traces of DNA from a patient with retinitis pigmentosa mapping 
to chromosome 2p15-p11,the reasrcher analyzed the candidate gene FAM161A and 
identified a homozygous mutation that was found in families with the disease. Screening 
of FAM161A in 118 patients from Germany with recessive or sporadic forms of RP 
revealed the presence of another homozygous mutation in 3 patients (Gu et al., 
1999; Langmann et al., 2010).  
 
In 2014, the researcher performed a clinical and molecular genetic study of a 
consanguineous Palestinian family with two three siblings affected with retinitis 
pigmentosa. DNA samples were collected from the index patient, his father, his affected 
sister, and two non-affected brothers. Funduscopic examination revealed a typical 
appearance of advanced RP with optic disc pallor, narrowed retinal vessels, bone-spicule 
like pigmentary changes in the mid-periphery and atrophic changes in the macula. 
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The younger affected brother (37 years) was reported with overall milder symptoms, while 
the youngest sister (21 years) reported problems only with night vision. Sequencing 
analysis revealed the presence of a novel homozygous nonsense mutation, 
c.1003C>T/p.R335X in the index patient and the affected sister (Zobor et al., 2014). 
 
1.11.2 Cyclic Nucleotide-Gated (CNG) Cation Channels A3: 
 
Cyclic nucleotide-gated (CNG) cation channels are essential in visual and olfactory signal 
transduction. These proteins, CNG1 and CNG2, are encoded by 2 different genes. The 
CNG1 channel is activated at 40-fold higher cGMP concentrations than the CNG2 channel 
(Biel et al., 1994) .Complete achromatopsia or rod monochromatism is a stationary cone 
dystrophy, with an incidence of 1 in 30 000, in which functional cones are absent from the 
retina (Sharpe et al., 1999). Studies of patients with achromatopsia have revealed more 
than 40 disease causing mutations in CNGA3, the majority being missense mutations. In 
the patient groups studied, four CNGA3 mutations (Arg277Cys, Arg283Trp, Arg436Trp, 
and Phe547Leu) accounted for 40% of all mutant CNGA3 alleles (Wissinger et al., 2001).  
 
Total colorblindness, also referred to as rod monochromacy or complete achromatopsia, is 
a rare congenital autosomal recessive disorder characterized by photophobia, reduced 
visual acuity, nystagmus, and the complete inability to discriminate between colors. 
Electroretinographic recordings show that in achromatopsia the rod photoreceptor function 
is normal, whereas cone photoreceptor responses are absent (Kohl et al., 1998 ).In 
complete achromatopsia, cone photoreceptors, the retinal sensory neurons mediating color 
vision, seem viable but fail to generate an electrical response to light. The CNGA3 gene 
encodes one of a family of alpha subunits that form CNG ion channels required for sensory 
transduction in rod photoreceptors and in olfactory neurons. The CNG3 channel consists 
of CNGA3 and CNGB3 in a heterotetrameric structure of 2 alpha and 2 beta subunits 
(Sundin et al., 2000). 
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In 1998, the researcher  performed linkage analysis in 8 families with total colorblindness, 
also known as rod monochromacy or achromatopsia, an autosomal recessively inherited 
condition. Linkage was found with markers located at the pericentromeric region of 
chromosome 2. Further homozygosity mapping refined the locus to an interval of 
approximately 3 cM covering the locus, which they designated ACHM2 (Wissinger et al., 
1998). 
 
The researcher screened for CNGA3 mutations in 258 independent families with hereditary 
cone photoreceptor disorders and found CNGA3 mutations not only in patients with the 
complete form of achromatopsia, but also in patients with incomplete achromatopsia and 
even in a few patients diagnosed with severe progressive cone dystrophy (Wissinger et al., 
2001). In 2007,the researcher analyzed the CNGA3, CNGB3, and GNAT2 genes in 16 
unrelated patients with autosomal recessive ACHM: 10 patients had mutations in CNGB3, 
3 had mutations inCNGA3, and no coding region mutations were found in 3 patients. The 
authors concluded that CNGA3 and CNGB3 mutations are responsible for the substantial 
majority of achromatopsia. In a study of 15 Chinese patients from 10 unrelated families 
with ACHM, Liang et al. (2015) identified CNGA3 mutations in 13 patients from 8 
families (Wiszniewski et al., 2007) .  
 
In a female patient from a consanguineous Saudi Arabian family who had been diagnosed 
with Leber congenital amaurosis, the researcher identified homozygosity for a missense 
mutation in the CNGA3 gene that segregated with disease in the family. The mutation, 
located at a conserved residue in the cGMP-binding domain, was not found in 200 controls 
or in the dbSNP130 or 1000 Genomes databases. The female patient had nystagmus noted 
shortly after birth, and electroretinogram was nonrecordable at 10 months of age. At 2 
years of age she was noted to have very sluggish pupils and no visual responses were 
elicited (Wang et al. 2011). 
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1.11.3 Human sapiens Crumbs Family member 1 Gene: 
 
CRB1 is a human homologue of the Drosophila melanogaster gene coding for protein 
crumbs (crb), which is expressed in the retina and the brain (Hollander et al., 1999). 
Mutations in the CRB1 gene are associated with variable phenotypes of severe retinal 
dystrophies, ranging from Leber Congenital Amaurosis (LCA) to rod-cone dystrophy (also 
called retinitis pigmentosa (RP)) (Benayoun et al., 2009). In 2004,the researcher stated that 
71 different sequence variants had been identified in the CRB1gene in patients with retinal 
dystrophies. They provided an overview of currently known CRB1variants and discussed 
their effects ( Hollander et al., 2004) .  
 
The researcher sought to identify CRB1 mutations in a large cohort of patients with 
recessive retinal dystrophies and to document the retinal phenotype and visual prognosis. 
They recruited 306 patients with Leber congenital amaurosis (LCA), early-onset childhood 
retinal dystrophy, or juvenile-onset retinitis pigmentosa to the study. Mutations in CRB1, 
including 17 novel mutations, were identified in 41 patients from 32 families, and those 
patients underwent detailed phenotyping. Common phenotypic features included 
hypermetropic refractive error, nummular pigmentation at the level of the retinal pigment 
epithelium (RPE), and increased retinal thickness on optical coherence tomography (OCT) 
( Henderson et al., 2011). 
 
In 2012, the recearcher  analyzed the CRB1 gene in 400 index patients with a provisional 
diagnosis of retinitis pigmentosa and identified 11 patients carrying likely pathogenic 
variants of CRB1. Analysis of the more than 150 previously reported CRB1 mutations and 
the clinical features of the respective patients showed that no specific allele combination 
could be assigned to a particular phenotype ( Bujakowska et al., 2012). Because of the 
early onset of disease in patients who have retinal pigmentosa with preserved paraarteriolar 
retinal pigment epithelium (RP12), with severe loss of vision at ages of less than 20 
years, den Hollander et al. considered CRB1 to be a good candidate gene for Leber 
congenital amaurosis. They detected mutations in CRB1 in 7 (13%) of 52 patients with 
LCA from the Netherlands, Germany, and the United States ( Hollander et al., 2001). 
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Chapter 2 
 
Materials and Methods 
 
2.1 Study design  
 
This descriptive study was aimed to recruit consanguineous Palestinian families with more 
than one family member suffering from clinical signs of reduced vision, night blindness 
and retinopathies. The target individuals were selected among patients attending 
ophthalmological clinics in the West-Bank. Venous blood sample of 5 ml. Samples were 
collected from whole blood samples using QIAamp® DNA Mini Kit, DNA was extracted 
from all family members (affected and phenotypic healthy individual) including the 
parents.  Review of the achieved clinical data and the literature review were need to guide 
us to detect the possible mutation causing such ophthalmic disorders in each family. 
 
2.2  Preliminary Pilot study 
 
A preliminary work was conducted on patients with reduces vision from consanguineous   
families. There clinical examination showed various degree of reduced vision with night 
blindness. A fundoscopic examination revealed Fundus Albipunctatus characteristic for 
retinitis pigmentosa. Genetic examination of the DNA samples extracted from the collected 
whole blood samples from all family members revealed the presence of gene mutation in 
the affected individual and others with healthy phenotype. 
 
Samples were collected after signing a written consent from all individuals participating in 
the study. A pedigree drawing software (http://www.cegat.de/en/for physicians/pedigree-
chart-designer/) was used to draw the pedigree and to identify the level of cousinship and 
consanguinity in the target family. Clinical investigation was performed with the assistance 
of ophthalmologist in Musallam Specialty Hospital and private clinics with review of 
family  history  of consanguinity. Laboratory part (blood sample collection delivery , 
extraction of DNA from blood was performed using QIAamp® DNA Mini Kit, and then 
the quantity and quality of  DNA  at the medical research lab AQU was determine . 
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2.3 Samples collection 
 
A total of  129 individuals (18 Palestinian consanguineous families) were used in this 
study. Target families are residents of different Palestinian Governorates; Ramallah, 
Hebron , Bethlehem, Gaza, Nablus and Jericho during  the period between November 2014 
to November 2016. Attending ophthalmological clinics in private and governmental 
hospital. 5 ml of blood were collected from each family members (affected and phenotypic 
healthy ones) including the parents in EDTA tube. Examinations were carried out 
respecting the Code of Ethics of the World Medical Association (Declaration of Helsinki). 
Informed consent was obtained from all family members. Blood was delivered in a cold 
box to Al-Quds Medical research laboratory - Al-Quds University and stored at −20˚C for 
future analysis. 
 
2.4 DNA extraction 
 
Genomic DNA was prepared from peripheral venous blood using QIAamp® DNA Mini 
Kit and stored in TE buffer in Palestine. Whole genome SNP genotyping was done using 
Affymetrix 250k_NspI SNP arrays (Affymetrix, Santa Clara, CA) in Germany (Ditta 
Zobor, 2014). SNP chip genotypes were used for mapping of homozygous regions 
applying the online version of the Homozygosity Mapper software (Seelow D, 2009). 
 
DNA extracted from all family members(affected and phenotypic healthy ones) including 
the parents.The procedures this kit were Pipet 20 μl QIAGEN Protease (or proteinase K) 
into the bottom of a 1.5 ml microcentrifuge tube.Then was added 200 μl sample to the 
microcentrifuge tube and was added 200 μl Buffer AL to the sample. The mix was 
incubated at 56°C for 10 min. Briefly centrifuge the 1.5ml microcentrifuge tube to remove 
drops from the inside of the lid. Thin was added 200μl ethanol (96–100%)to the sample, 
and mix again by pulse-vortexing for 15s. After mixing, briefly the sample was centrifuged 
to remove drops from the inside of the lid. Close the cap, and centrifuge at 6000 x g (8000 
rpm) for 1 min. QIAamp Mini spin column was opend and was added 500 μl Buffer AW1 
without wetting the rim. The cap was closed and was centrifuged at 6000 x g (8000 rpm) 
for 1 min. 
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The QIAamp Mini spin column was opend and was added 500 μl Buffer AW2. The sample 
was centrifuged at full speed (20,000 x g; 14,000 rpm) for 3 min. The QIAamp Mini spin 
column was placed in a clean 1.5 ml microcentrifuge tube and was discard the collection 
tube containing the filtrate. It was opend the QIAamp Mini spin column and was added 200 
μl Buffer AE or distilled water. The sample was incubated at room temperature (15–25°C) 
for 1 min, and then was centrifuged at 6000 x g (8000 rpm) for 1 min.Finally , DNA was 
stored at -20c . DNA samples were amplified as in Table ( 2.2 ) and loaded into the gel. 
DNA marker ladder of 100bp (Thermo scientific Lithuania) was used in each run. 
 
2.5 Amplification of DNA 
 
2.5.1 Primers design and DNA amplification: 
 
In this study, new primers were designed based on the conserved DNA sequences of three 
genes references retrieved from the Gene Bank (FAM161A, CNGA3 and CRB1). All 
sequences were aligned to each other using the program 
(http://multalin.toulouse.inra.fr/multalin/ ) to detect nucleotide variations within these 
sequences which can be used for further mutation identification as shown in appendix A.6 
and B.6.  
 
The primer3 website program was used for primer design 
(http://www.primer3plus.com/cgi-bin/dev/primer3plus.cgi) as shown in appendix A, B and 
C. Three sets of primers (forward and reverse) were used as shown in Table (2.1).  
 
Polymerase chain reaction (PCR) was used to amplify three genes (FAM161A, 
CNGA3 and CRB1). 
 
FAM161A mutation was mentioned as a novel mutation in new study 
(c.1003C>T/p.R335X) as a nonsense  mutation (Reference Sequence: 
NM_001201543) (Zobor, 2014). This mutation was identified on its reference 
sequence comparing with the normal sequence without mutation starting from the 
coding sequence after 103 bases. 
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According  to  a  previous  study  in  two  Jordanian  patients  with  a  diagnosis  of 
achromatopsia  have  a  mutation  on  GNGA3  gene  c.985G>T  ‐ Gly329Cys  (Genead, 
2011). We followed this mutation on its Reference Sequence: NM_001298.2, then we 
located the normal sequence starting from the coding sequence after 418 bases. 
 
Recent study in the Palestinian populations on retinal degeneration showed a mutation on 
CRB1 gene c.3307G>A/p.Gly1103Arg (Avigail Beryozkin, 2013). we had identified  this 
mutation in its Reference Sequence: NM_201253.2, then we located the normal sequence 
without the mutation starting from the coding sequence after 210 bases, and then we did 
many steps to get the ARMS technique.
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Table 2.1: The main properties of the primers used in this study. 
 
 
 
 
The final concentration of working primers was 10 μM/ml. We mixed primers from 
forward and reverse (10 μM F +1 0 μM R) with 80 μM ultrapure water. For DNA 
amplifications, PCR reactions were performed in 25-μl PCR .We had prepared PCR mix 
that contained  2.5 μM of mix primers , 2.5 μM of Red master mix , 15.5 μM of DW and 
2μl of the extracted DNA. The DNA samples were amplified using Bio Rad thermal cycler 
according to conditions in Table (2.2). Nuclease-free water was used as negative control in 
each run.  
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                  Table 2.2 : PCR conditions used for amplifying DNA samples. 
 
 
 
 
2.5.2 Gel electrophoresis: 
 
All PCR products were separted on 2 % agarose gel (Agarose LE, Analytical gradient, 
Promega, Spain). The gel was prepared by dissolving 2g of agarose in 100 ml solution of 
1X Tris-acetate EDTA buffer (TAE) (40 mM of Tris acetate and 1mM EDTA). The 
agarose was dissolved in Erlenmeyer flask using microwave for about 1min till completely 
dissolved, and then 3.5µl of 10 mg/ml (0.35µg/ml) of Ethidium Bromide was added for 
DNA staining. The gel was poured in the gel tray in the casting chamber (Bio-Rad 
Laboratories Inc., USA). PCR products were loaded onto the gel. DNA marker ladder of 
100bp (Thermo scientific Lithuania) was used in each run.  
 
2.5.3 DNA sequencing: 
 
The PCR products of successfully amplified  samples ( n= 4) were sent for sequencing in 
both directions using forward and reverse primers as shown in appendix (D). At HyLab 
sequencing service (Rehovot, Israel) the PCR reactions and conditions were performed as 
described above. 
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Chapter 3 
 
Results 
 
3.1  Sample collection  
 
A total of 129 samples were collected from 18 consanguineous Palestinian families 
residing in different regions of Palestine: 43 samples were obtained from Ramallah , 34 
from Hebrew, 19 from Bethlehem, 16 from Gaza, 9 from Nablus and 8 from Jericho as in 
(Fig. 3.1).Overall, samples collected from individuals with affected phenotypes (night 
blindness and loss vision)  (n= 39/129; 30%) and from individuals with healthy phenotype  
(n= 90/129; 70%) as in (Table 3.1).  
 
To determine the severity of disease (39 affected individual) , the retina of the patient was 
examined use Slit Lamp Examination with (90),(78) lens . The severity depends on the 
locatopn of spots (peripheral v.s central , macula and optic disk )as in (Table 3.2).Table 3.3, 
shows the Distribution of onset of disease for affected individuals. 
 
 
Figure 3.1: The geographic distribution of the blood sample collected from Palestine, the number of 
collected blood per district was indicated. http://www.istockphoto.com/vector/state-of-palestine-west-bank-
and-gaza-strip-political-map. 
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Table 3.1: Distribution of samples ( affected and unaffected phenotype ) by region. 
 
 Severity Location of spots Valid Percent 
    
 Peripheral 15 38.5 % 
 Central 10 25.7 % 
 Macula 2 5 % 
 Optic disk 0 0 % 
 Not tested 12 30.8 % 
 Total 39 100 % 
 
 
Table 3.3: Distribution of onset of disease for affected individuals. 
 
Onset of disease Number of patient Valid Percent 
   
At birth 22 56.3 % 
   
2 – 15 years 11 28.3 % 
   
15 – 25 years 6 15.4 % 
More than 25 0 0 % 
   
Total 39 100 % 
   
 
  Region 
Number of 
family 
Number of 
Affected 
phenotype 
Number of 
unaffected  
phenotype 
     
 Ramallah 5 14 29 
 Hebron 4 9 25 
 Bethlehem 3 7 12 
 Gaza 2 4 12 
 Nablus 2 2 7 
 Jericho 2 3 5 
     
 Total 18 39  (30 %) 90  (70 %) 
     
  
 
  
Table 3.2: Distribution of retinal spots location on fundoscopy and severity severity . 
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3.2 Three mutatons detected in index patients  
 
To determine the target gene for each family member, after DNA extraction from all 
family members ,the index patient in each family had been considered as a target for gene 
mutation search. PCR products prepared and DNA samples were amplified as in Table        
( 2.2 ) and loaded into the gel. DNA marker ladder of 100bp (Thermo scientific Lithuania) 
was used in each run. The gel was run at 100V for 45min. In (Fig. 3.2),(Fig. 3.3) and (Fig. 
3.4), Respectively, PCR products of FAM161A, CNGA3 and CRB1 genes for the index 
patient in each family (n = 18) . 
 
 
 
Figure 3.2: PCR products of FAM161A gene. M: Mutant primer , N: Normal primer, Lanes (1, 2, 
3,4,5,6,7,8 and 9 ) are number of sample for 9 families , L: DNA ladder (100 bp), and C : negative control . 
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In (Fig. 3.2) , The first band (Red Colure) on the family number one appeared on the 
mutant sample which means that the sequence of the allele bonded at the mutant primer 
(5’-caagggaggaacagaagt-3) and no band in normal sample. This mean, the index patient in 
family number one has mutation in FAM161A gene because the band appeared in mutant 
column. Bands appeared in normal samples, this mean normal allele attached to the normal 
primer (5’-caagggaggaacagaagc-3’) and no bands appeared in mutant samples 
(M2,M3,M4,M5,M6,M7,M8 and M9),. 
 
 (Fig. 3.3) explains same results, No band appeared in mutant samples 
(M11,M12,M13,M14,M15,M16,M17 and M18), just appeared in normal samples.The 
result showed no FAM161A mutation in these families. 
 
 
Figure 3.3: PCR products of FAM161A gene. M: Mutant primer , N: Normal primer, Lanes (10, 11, 
12,13,14,15,16,17,18 and 19 ) are number of sample for other 9 families , L: DNA ladder (100 bp), and C : 
negative control . 
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Figure 3.4: PCR products of CNGA3 gene. M: Mutant primer , N: Normal primer, Lanes (from 1 to 18 ) 
are number of sample for 18 families , L: DNA ladder (100 bp), and C : negative control . 
 
(Fig. 3.4) is showing the present of CNGA3 mutation among selected 18 index patient. The 
bands appeared on the mutant sample number 2 and 5, which means that the sequence of 
the allele bonded at the mutant primer (5’-gccatttccaagttcattt-3’) and no band in normal 
sample. This mean , index patient in families number 2 and 5 have mutation in CNGA3 
gene. In samples (M1,M3,M4,M6,M7,M8,M9 and to M18),  No bands appeared in mutant 
samples and appeared in normal samples, this mean normal allele attached to the normal 
primer (5’-gccatttccaagttcattg -3’) so no mutation in CNGA3 in this families.  
 
 
Figure 3.5 : PCR products of CRB1 gene. M: Mutant primer , N: Normal primer, Lanes (from 1 to 18 ) are 
number of sample for 18 families , L: DNA ladder (100 bp), and C : negative control . 
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No bands appeared in all mutant samples (M1 to M18), bands appeared in normal samples, 
this mean normal allele attached to the normal primer ( 5’ ctaagtacaatagaaatc 3’ ), 
so no CRB1 mutation was detected in all index patient. 
 
Finally based on this approached the presence of FAM161A mutations and CNGA3 
mutations in families ( AQ 01, AQ 02 and AQ 05 ), respectively, is guiding us to search for 
the given mutation despite the healthy or affected phenotype of the individual.  
 
3.3 Constructing of pedigree of target families 
 
During the recruitment of families and in order to generate pedigree for the target families, 
the cegat pedigree chart designer software was used. The recruitment familes carried the 
codes AQ n-1-2 ( AQ refers to  Alquds University,  n:number of  the case, 1: number of 
generation ( first ,second ,… etc ), 2: order of each person in the generation ) to consider 
the privacy of participating families. The pedigrees of the consanguineous families are 
shown in (Fig. 3.6) and (Fig. 3.8) . 
 
 
 
 
Figure 3.6 : Pedigree of AQ 01 (The family had FAMA161A mutation). 
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Figure 3.7: PCR products of FAMA161A gene for the first family (AQ 01). M: Mutant primer , N: 
Normal primer, Lanes (from 1 to 2 ) are number of samples for two families , L: DNA ladder (100 bp), and C 
: negative control ). 
  
 
Table 3.4 : Genotypes of AQ 01. 
 
Code Gender Status (Phenotype) Genotype 
AQ1-01-01 Male Unaffected father NO Blood sample  
AQ1-01-02 Female Unaffected mother Died 
AQ1-02-01 Male Unaffected  FAM161A: Normal 
AQ1-02-02 Female Affected  No blood sample 
AQ1-02-03 Male Affected FAM161: 
Homozygous mutation 
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Figure 3.8 : Pedigree of AQ 02 and AQ 05 (The families had CNGA3 mutation).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.9: PCR products of CNGA3 gene for the second family (AQ 02). M: Mutant primer , N: Normal 
primer, Lanes (from 1 to 6 ) are number of samples for two families , L: DNA ladder (100 bp), and C : 
negative control ).  
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Figure 3.10: PCR products of CNGA3 gene for the third family (AQ 05). M: Mutant primer , N: Normal 
primer, Lanes (from 1 to 9 ) are number of samples for two families , L: DNA ladder (100 bp), and C : 
negative control ).  
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Table 3.5: Genotypes of AQ 02 family . 
 
Code Gender Status Genotype 
AQ2-01-01 Male Unaffected father CNGA3: Heterozygous 
mutation 
AQ2-01-02 Female Unaffected mother CNGA3: Homozygous 
mutation 
AQ2-02-01 Male Affected CNGA3: Heterozygous 
mutation 
AQ2-02-02 Female Unaffected CNGA3: Homozygous 
mutation 
AQ2-02-03 Male Affected, twin to 
AQ2-02-04 
CNGA3: Homozygous 
mutation 
AQ2-02-04 Female Unaffected, twin to 
AQ2-02-03 
CNGA3: Normal 
 
AQ5-01-01 Male Unaffected father CNGA3:Heterozygous 
mutation 
AQ5-01-02 Female Unaffected mother CNGA3: Normal 
AQ5-02-01 Male Affected CNGA3:Homozygous 
mutation 
AQ5-02-02 Male Affected CNGA3:Homozygous 
mutation 
AQ5-02-03 Male Affected CNGA3:Heterozygous 
mutation 
AQ5-02-04 Male Unaffected CNGA3:Heterozygous 
mutation 
AQ5-02-05 Female Unaffected CNGA3:Homozygous 
mutation 
AQ5-02-06 Female Unaffected No blood sample 
AQ5-02-07 Male Unaffected CNGA3:Homozygous 
mutation 
AQ5-02-08 Female Affected CNGA3:Homozygous 
mutation 
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Chapter 4 
 
Discussion 
 
Consensual marriage is present in palestine with high rate,  but the highest rates of marriages to 
close relatives are consistently reported in the more traditional rural areas and among the poorest 
and least educated society, these findings were expected in all villages of the study area, which 
gives a rise to so many genetic disorders related to this marriage, Especially rare autosomal 
recessive disease genes. 
 
One opthalmic disorder considered to be the most important disorder assocaiste with 
retinopoahty as autosomal recessive disease “Rhinitis pigmentosa”. In target familles, all family 
members were screened regaedless of their phenotype. 
  
For this purpose , we had developed a simple , cost effective, fast method to detect the presece of 
one or more of the three studied mutations. In this study, the aim of the project was 
accomplished to design a new and test by using amplification-refractory mutation system 
(ARMS). This method is characterized cheap and timesaving that detecting the presence of 
FAM161A (c.1003C>T/p.R335X), CNGA3 (c.985G>T, Gly329Cys). One of the drawback of 
this method to show  similar achievements in CRB1 gene detection,  
 
Therefore, the ARMS method for deteced FAM161A gene in AQ (01) family was very 
successful (Fig. 3.7). The first band (AQ 01-02-01) appeared at the normal site meaning that the 
normal allele attached to the normal, the second band (AQ 01-02-03) appeared at the mutant 
primer meaning that the sequence of the allele linked to the mutant primer, this means,that 
sample (AQ 01-02-03) had homozygous mutation . 
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The ARMS method for CNGA3 gene scaning was effective in all samples for the two family 
examined in the study (AQ 02 and AQ 05) (Fig. 3.9) and (Fig. 3.10).In AQ 02, all family 
members had mutation in CNGA3 gene except last member (AQ02-02-04). In two members 
(AQ02-01-01 and AQ02-02-01), bands appeared at the normal and mutant site meaning that the 
sequence of the allele linked to forward and reverse primers  , meaning that the mutation is 
heterozygous . 
 
In other mutant family members, bands appeared at the mutant primer, that means that the 
mutation is homozygous mutation .In AQ (05), all family members had mutation in CNGA3 
gene except one member (AQ05-01-02). In three members (AQ05-01-01, AQ05-02-03 and 
AQ05-02-04), bands appeared at the normal and mutant site meaning that the sequence of the 
allele linked to reverse and forward primers, meaning they had a heterozygous mutation . In 
other mutant family, have members (AQ05-02-01, AQ05-02-02, AQ05-02-05, AQ05-02-07  and 
AQ05-02-08), bands appeared at the mutant primer (5’-gccatttccaagttcattt-3’), that means the 
mutation is a homozygous. Finally, CRB1 gene mutation wasn’t detected in all familes as shown 
in (Fig. 3.5), bands appeared at the normal site which means that the normal allele attached to the 
normal primer . 
 
The ARMS technique worked well in FAM161A and CNGA3 genes detection, but it didn’t 
function with CRB1 gene. These results can lead us to search more in this field in the future 
researches since the results of this research confirm the outcomes of ARMS technique which 
were positive.  
 
Finally, we show a very high diagnostic yield of DNA sequencing for a highly diverse spectrum 
of ophthalmic disorders in patients from Arab families of the Palestinian territories, even with 
limited prior clinical history. Applying targeted genes, we were able to identify the mutations 
causing diseases in three out of 18 consanguineous families (= 17%) and thus providing a 
molecular diagnosis for the families and physicians. 
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Appendix A  
 
Primer design , aligment and DNA sequencing of  FAM161A gene 
 
 
 
 
Figure A.1 : The sequence location of forward primer (on label) that we design for FAM161A gene 
from NCBI site.  
 
 
 
 
Figure A.2 : The sequence location of reverse  primer (on label) that we design for FAM161A gene 
from NCBI site.  
 
 
 
 
Figure A.3 : The result that obtained from primer 3 site when we design the forward and reverse 
primers for FAM161A gene. 
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Figure A.4 : BioEdit software for analysis of the obtained DNA sequences for normal FAM161A 
gene (Red marker). The DNA sequences were analyzed and arranged to prepare them for BLAST 
analysis step. 
 
 
 
 
 
Figure A.5 : BLAST of FAM161A sequence againts refernce strains sequence. 
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Figure A.6 : The result of aligment from BLAST for FAMA161A gene (Red marker is site of 
mutation).  
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Appendix B 
 
Primer design , aligment and DNA sequencing of  CNGA3 gene 
 
 
 
 
Figure B.1: The sequence location of forward primer (on label) that we design for CNGA3 gene 
from NCBI site. 
 
 
 
 
 
Figure B.2: The sequence location of reverse (on label) that we design for CNGA3 gene from NCBI 
site.  
 
 
 
 
Figure B.3: The result that obtained from primer 3 site when we design the forward and reverse 
primers for CNGA3 gene. 
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Figure B.4 : BioEdit software for analysis of the obtained DNA sequences for mutant CNGA3 gene 
(Red marker). The DNA sequences were analyzed and arranged to prepare them for BLAST analysis 
step 
 
 
 
 
 
Figure B.5: BLAST of CNGA3 sequence againts refernce strains sequence. 
 
 
 
 
Figure B.6: The result of aligment from BLAST for CNGA3 gene(Red marker is site of mutation).  
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Appendix C 
 
Primer design of  CRB1 gene 
 
 
 
 
Figure C.1: The sequence location of forward primer (on label) that we design for CRB1 gene from 
NCBI site.  
 
 
 
 
Figure C.2 : The sequence location of reverse  primer (on label)that we design for FAM161A gene 
from NCBI site.  
 
 
 
 
Figure C.3 : The result that obtained from primer 3 site when we design the forward and reverse 
primers for CRB1 gene. 
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Appendix D 
 
 
DNA sequencing for FAM161A and CNGA3 gene 
 
 
 
 
 
Figure D.1: BioEdit software for analysis of the normal  DNA sequences for FAM161A gene 
(Red marker was normal ).  
 
 
 
 
 
Figure D.2 : BioEdit software for analysis of the mutant  DNA sequences for FAM161A gene (Red 
marker was mutant ). 
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Figure D.3 : BioEdit software for analysis of the normal  DNA sequences for CNGA3 gene 
(Red marker was normal ).  
 
 
 
 
 
 
Figure D.4: BioEdit software for analysis of the mutant DNA sequences for CNGA3 gene 
(Red marker was mutant ). 
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  E xidneppA
 
 
 srebmem ylimaf lla rof mrof tnesnoC
 
 
 
 الموافقة المسبقة للمرضى
 
 
  سم)_______________________________________( اريخ  الملاد)_________________الا(
 
  رلتشخلص الوياثي وآثريه. المتعلق بعن المشروع البحثي ، و لقد القلت فكرة واضحة  -
  بلدي بشأن التفسلرات الممكنة والقلو) المفروضة على اختبري الوياثلة منهر. في  لقد القلت معلومرت كرملة من الطبلب -
  للس لدي المزخد من الأسمئلة. -
من  يفي هذه الحرلة ، سملت) اجرهل البلرنرت الخرصة بي وعلنراولسحب مشريكتي )ون إبداء أي سمبب. أنر حر وامرمر.  ةأن مشريكتي طوعلب أقر -
  نسحر  أي خسرية في الاسمتحقرقرت برلنسبة لي. خشكل هذا الالاوي. والحمض النو
  نلة.رلي اسمتخراج الحمض النووي والاختبريات الجلبرلت ، و علنة الدم الويخديسمحب أنر اوكد الموافقة على  -
لتحللادت الجلنلة ضمن هذا ا لعمل لمرنلر_في اوبنغن (أ السرخرخة معهد أبحرث الدمرغ الىبلدي من ايسمرل علنة الحمض النووي  وأنر اوافق على -
  لدي.لتحدخد الأسمرس الجلني للمرض و لتخزخنهر روع المش
  كرلترلي: تييت أنه برلامكرن اسمتخدام علنوبرلإضرفة إلى ذلك ، لقد قر
 
  لاأو  : نع)  ى  الأجربة خرج
 
 
 لا    نعم     
رث الدمرغ في اوبنغن ، ألمرنلر لاسمتخدامه في مشريخع أخرى في معهد أبح أن خت) اخزخن الحمض النووي الخرص بي
  حتى أعلن انسحربي يمرض حول
  
ثي ولا البي معرخلر بأن النترئج استند على مشروع بح ى إطادع حول النترئج. لقد ا) إبادغيأامنى أن أكون عل
 التشخلص الجلنلة الروالنلة.
  
    سمنوات في اوبنغن ، ألمرنلر. 10كثر من لأبلرنرت هر مع الالجلنلة سملت) اخزخن ينترئجعلى أن  أوافق
 
 
 
 مادحظرت إضرفلة 
 
 الطبلب المحول  
 
 
 
 
 اوقلع الطبلب  اريخ  التوقلع المكرن 
 
 المرخض / الوصي القرنوني
 
 المرخض / الوصي القرنوني  التوقلع المكرن اريخ 
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الناتجة من زواج الاقارب بواسطة التحليل الجيني   yhtaponiteR  الجينات الوراثية البصرية المتعلقة بأمراض شبكية العينتحديد 
الجزيئي من عدة محافظات فلسطينية مختلفة.
 
 
إعدا): محمد موسمى مصطفى فلنة
 
 
 
إشراف: ). غسرن بعلوشة
 
 
 
الملخص:
 
ت الشرق الأوسمط وبرلأخص في المنرطق القروخة من المتجذية في مجتمعرخعد زواج الأقري  من العر)ات 
ان الطفرات الذاالة المتنحلة  ي والاجتمرعي لهذه المجتمعرت.المجتمعرت العربلة وخرجع ذلك للمويث الثقرف
  ي لهر عادقة كبلرة بزواج الاقري .والمويثة لمرض التهر  الشبكلة الصبرغ
 
 وعر)ة مر خكون زواج الاقري  من الديجة الاولى وفي حرلات اخرى خكون من )يجرت ابعد )اخل العرئلة.
ان انتشري الامراض الوياثلة النراجة عن طفرات متنحلة منتشرة انتشري كبلرا في المجتمعرت العربلة نظرا لتكراي 
 زواج الاقري  من جلل الى جلل.
 
خر طرخقة سمهلة بسلطة التكرللف للكشف عن وجو) ثادث طفرات اسمرسملة ان الهدف من هذه الدياسمة هو اطو
  ومسببة لمرض التهر  الشبكلة الصبرغي
  وذلك عن طرخق اكنولوجلر  
 
زواج اقري  وخوجد في كل عرئلة اكثر من عرئلة فلسطلنلة لا10قمنر بتصملمه للطفرات الثادث واشمل الدياسمة 
في هذه الدياسمة وبرسمتخدام هذه الطرخقة في طرح طرخقة يخلصة  لقد نجحنر شخص خعرني من مشركل بصرخة.
لقد حد)ت  هذه الطرخقة الانمرط . (طفرة_ التكرللف وسمهلة الا)اء للكشف عن أي اغللر في القرعدة للحمض الاملني
 الجلنلة للمرض بتحدخد نوع الطفرة لدخه) ومر اذا كرن المرخض متمرثل اوغلر متمرثل   
  ث المقترحة.في الطفرات الثاد
 
امرت هذه الطرخقة هو احدخد ان من اسمتخد قل التكرللف.طرخقة وبأللرت مخبرخة بسلطة لتنفلذ هذه البرسمتخدام أوذلك 
طوال مختلفة بعد اذوخب الحمض ة جلنلر بوجو) قطع بأحلث خت) احدخد الفرق في علنرت الحمض النووي المتمرثل 
 النووي بمر)ة                    
 
   و) او عدم وجو)ان وج
 
ان لمرضى التهر  الشبكلة الصبرغي وعرئاداه) احتلرجرت معقدة اشمل التكلفة البرهظة للتشخلص والعادج وقد 
جرءت هذه الطرخقة لتخفف اكلفة اشخلص المرخض واحدخد الطفرة لدخه خصوصر وان معظ) المرضى خنحديون 
 من مجتمعرت قروخة فقلرة.
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طفرات خت) البحث عنهر بواسمطة هذه التكنولوجلر ان اثنرن                                          من اصل ثادث 
امر برلنسبة للطفرة الثرلثة           عرئلة مشتركة في الدياسمة.10عرئادت من اصل  3المقترحة ا) الكشف  عنهر في 
  فل) خت) الكشف عنهر.  
  
 
لبسلطة وبتكرللف يخلصة اظهر النترئج النجرح في الكشف عن الطفرات المذكوية اعاده برسمتخدام هذه التكنولوجلر ا
اقري  لكن خت) احدخد GHممر خعزز اعتمر) هذه الطرخقة في فحص مرض العلون المنحدية من عرئادت بزواج 
  .النمط لجلني لمرضه) برجراء يوالني بسلط وسمرخع وسمهل
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